MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The association between motor laterality and cognitive impairment in Parkinson’s disease

    J.S. Kim, J.W. Cho, J. Youn (Seoul, Republic of Korea)

    Objective: Our study aimed to compare the cognitive function depending on the one-sided symptom dominance for investigating association between specific cognitive function and asymmetric motor…
  • 2017 International Congress

    Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson’s disease

    H. Sawada, S. Orimo, A. Inaba, M. Takahashi (Tokyo, Japan)

    Objective: The objective of this study is to investigate a relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT SPECT (dopamine transporter (DAT) SPECT) in…
  • 2017 International Congress

    Feasibility of utilizing the NIH Toolbox in Parkinson’s disease subjects with deep brain stimulation

    J. Emerson, P. Dhruva, C. McLeod, R. Moses-Kessler, L. Metman, G. Pal (Chicago, IL, USA)

    Objective: To determine the feasibility of utilizing the NIH Toolbox in moderate to advanced disease Parkinson’s disease (PD) subjects with bilateral subthalamic nucleus deep brain…
  • 2017 International Congress

    High systolic blood pressure is associated with cognitive impairment in Parkinson’s disease (PD)

    H. Chan, Y. Cheung, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To assess if metabolic risk factors are associated with cognitive dysfunction in PD patients. Background: Metabolic syndrome is known as a risk factor of many…
  • 2017 International Congress

    Dopamine replacement influences on postural motor learning in Parkinson disease

    S. Paul, G. Olivier, C. Walter, S. Schaefer, L. Dibble (Salt Lake City, UT, USA)

    Objective: To determine if i) dopamine replacement affects general and sequence specific learning of a postural task in people with Parkinson disease (PD), and ii)…
  • 2017 International Congress

    Patient-reported hallucinations and the probability of progression to dementia in Parkinson’s disease

    K.-L. Horne, D. Myall, M. MacAskill, L. Livingston, S. Grenfell, T. Melzer, T. Pitcher, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To evaluate the influence of neuropsychiatric symptoms in identifying Parkinson’s disease (PD) patients who will progress to dementia (PDD) in the imminent future (~4…
  • 2017 International Congress

    The Impact of Cognitive Changes on Everyday Life for People with Parkinson’s: The Patient’s Perspective

    J. Wertheimer, A. Gottuso, A. Duboille, M. Tuchman, C. Walton (Los Angeles, CA, USA)

    Objective: To understand the patient’s perspective about cognitive changes in Parkinson’s disease and about the impact of cognitive dysfunction on daily life.   Background: Cognitive dysfunction is…
  • 2017 International Congress

    Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.

    M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)

    Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…
  • 2017 International Congress

    Risk Factors for Dementia in Parkinson’s disease

    M.I. Khalil, M.R. Rahman, S. Munira (Dhaka, Bangladesh)

    Objective: To investigate putative risk factors for the development of dementia in patients with Parkinson’s disease. Background: Dementia in idiopathic Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Ghrelin and the IGF-1 axis in cognitive impairment in PD

    F. Johnston, M. Siervo, A. Hornsby, J. Davies, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To explore the association of acyl-ghrelin (AG) levels with cognitive impairment (CI) in PD Background: Unintended weight loss (UWL) in PD is associated with…
  • « Previous Page
  • 1
  • …
  • 1284
  • 1285
  • 1286
  • 1287
  • 1288
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley